POS-274 A RANDOMIZED TRIAL OF EFFECT OF CHOLECALCIFEROL SUPPLEMENTATION ON CVD, INFLAMMATION AND BONE METABOLISM MARKERS IN CKD: DESIGN AND METHODS

POS-274 A RANDOMIZED TRIAL OF EFFECT OF CHOLECALCIFEROL SUPPLEMENTATION ON CVD, INFLAMMATION AND BONE METABOLISM MARKERS IN CKD: DESIGN AND METHODS

Bibliographic Details
Main Authors:	K. Manoharan, K. Kamboj, V.S. Gondal, V. Kumar, H.S. Kohli, V. Jha
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921004356

Similar Items

POS-400 EFFECT OF ORAL CHOLECALCIFEROL SUPPLEMENTATION ON SERUM LEVEL OF ANGIOGENIC MARKERS IN CHRONIC KIDNEY DISEASE
by: A.K. Yadav, et al.
Published: (2021-04-01)

THE ECONOMIC RATIONALE FOR THE SUPPLEMENTATION OF CHOLECALCIFEROL IN THE TREATMENT OF HYPERTENSION
by: Yakubova L. V.
Published: (2020-12-01)

ALGORITHMS FOR THE SUPPLEMENTATION OF CHOLECALCIFEROL IN THE TREATMENT AND PREVENTION OF HYPOVITAMINOSIS D IN ARTERIAL HYPERTENSION
by: Yakubova L. V., et al.
Published: (2019-09-01)

Interactions between CKD and MetS and the Development of CVD
by: Ken-ichi Aihara, et al.
Published: (2011-01-01)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
by: Hendrika J.M. Smelt, et al.
Published: (2019-06-01)

Body fat and cholecalciferol supplementation in elderly homebound individuals
by: M.H.S. Canto-Costa, et al.
Published: (2006-01-01)

Impact of additional cholecalciferol supplementation on the level of thyroid peroxidase antibodies in patients with primary hypothyroidism
by: I.V. Pankiv
Published: (2017-08-01)

Economic justification of blood pressure lowering costs in the complex therapy of arterial hypertension with Cholecalciferol supplementation
by: L.V. Yakubova, et al.
Published: (2021-04-01)

Association of Zinc Deficiency with Development of CVD Events in Patients with CKD
by: Shinya Nakatani, et al.
Published: (2021-05-01)

Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trial.
by: Lily Li, et al.
Published: (2014-01-01)

OUTCOME OF ZINC SUPPLEMENTATION ON NUTRITIONAL INTAKE OF CKD PATIENTS
by: N. Sahni, et al.
Published: (2012-06-01)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
by: Beena Bansal, et al.
Published: (2014-01-01)

POS-362 PRESCRIPTION PATTERN OF MEDICINE IN EARLY CKD STAGES IN ICKD COHORT STUDY
by: N. Prasad, et al.
Published: (2021-04-01)

Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report
by: Cupisti A, et al.
Published: (2015-11-01)

Correction of Vitamin D Deficiency with High Doses of Cholecalciferol
by: V.V. Povoroznyuk, et al.
Published: (2016-08-01)

Maternal cholecalciferol supplementation during gestation improves antioxidant capacities in gilts and piglets
by: Lianpeng Zhao, et al.
Published: (2021-01-01)

Effects of cholecalciferol supplementation in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients
by: Larissa Collis Vendramini, et al.
Published: (2021-06-01)

Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
by: Patrycja Grzejszczak, et al.
Published: (2021-07-01)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
by: Mark A Boyd, et al.
Published: (2017-11-01)

Prevalence of hypovitaminosis D and the different-dose cholecalciferol supplementation effects on renal transplant recipients
by: Sergio Mazzola Poli de Figueiredo, et al.
Published: (2016-01-01)

Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach
by: Eric Descombes, et al.
Published: (2014-01-01)

Erratum to CJCO 274
Published: (2021-07-01)

Disparity in cholecalciferol content of commercial preparations available in India
by: Rajesh Khadgawat, et al.
Published: (2013-01-01)

The Influence of Inflammation on Anemia in CKD Patients
by: Anna Gluba-Brzózka, et al.
Published: (2020-01-01)

Assessment of cholecalciferol and antihypertensive therapy concominant use in people with arterial hypertension
by: L.V. Yankouskaya, et al.
Published: (2017-04-01)

Open questions on bioequivalence: the case of cholecalciferol
by: Antonio Marzo, et al.
Published: (2013-09-01)

Studies in the metabolism of cholecalciferol in the Japanese quail
by: Nicholson, Russell Alfred
Published: (1976)

Review of bioequivalence studies of cholecalciferol drugs
by: Alexander L. Khokhlov, et al.
Published: (2020-09-01)

POS-259 MHR status as marker of 10-year risk and lifetime risk of recurrent Cardiovascular events in patients with CKD and Diabetes Mellitus
by: G. GEMBILLO, et al.
Published: (2021-04-01)

HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements
by: I. E. Shohin, et al.
Published: (2021-05-01)

POS-275 OSTEOPOROSIS IN CKD: PREVALENCE AND ASSOCIATED FACTORS IN A GUATEMALAN CENTER
by: C. Mazariegos, et al.
Published: (2021-04-01)

CKD in Disadvantaged Populations
by: Guillermo Garcia-Garcia, et al.
Published: (2015-04-01)

CKD in disadvantaged populations
by: Guillermo Garcia-Garcia, et al.
Published: (2015-03-01)

Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice
by: Artur Anisiewicz, et al.
Published: (2020-11-01)

Assessment of Physical Fitness after Bariatric Surgery and Its Association with Protein Intake and Type of Cholecalciferol Supplementation
by: Hendrika J. M. Smelt, et al.
Published: (2019-06-01)

Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol.
by: Katharina Wylon, et al.
Published: (2017-01-01)

Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy.
by: Yan Huang, et al.
Published: (2012-01-01)

Impact of compliance with cholecalciferol administration on the incidence of respiratory infections in young children
by: I. N. Zakharova, et al.
Published: (2020-11-01)

Study of the effect of the complex of active metabolites of cholecalciferol with vikasol on the state of periodontal tissues of rats
by: O. V. Нoncharenko, et al.
Published: (2019-01-01)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
by: Manuel Sosa Henríquez, et al.
Published: (2020-05-01)